Clifford Chance acted for Brookfield as anchor investor. Lanza Capital (formerly known as Firmum Capital) has raised €550m for its second fund focused on car park opportunities....
LanzaCapital’s €550 Million Financing Round
Artá Capital’s Acquisition of the Management Company and Launching of Fund III
Clifford Chance has advised the executives of Artá Capital. Artá Capital acquired the stake in the management company owned until then by Corporación Financiera Alba. The...
Minoryx Therapeutics and Neuraxpharm Group’s Development of a New CNS Therapy in Europe
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...